April 28, 2022
Dr. Joel Singer received his training in Clinical Epidemiology while serving as a Senior Research Associate in the Department of Clinical Epidemiology and Biostatistics at McMaster University.
While at McMaster, he worked with several different groups, first in the field of cardiovascular clinical trials, and later in the field of smoking cessation and the development of quality of life instruments.Read Less Read More
In 1990 he was appointed Assistant Professor at the University of British Columbia (UBC) to head the Data and Methodology Program at the CIHR Canadian HIV Trials Network (CTN). He continues as head of the program and is now a Professor at UBC’s School of Population and Public Health.
Dr. Singer has played an important role as the lead methodologist on numerous HIV clinical trials which have resulted in major publications in journals such as the New England Journal of Medicine, Lancet, and JAMA. At the same time, he has collaborated with researchers in a number of clinical disciplines, including rheumatology, neonatology, nephrology, intensive care, and emergency medicine to secure grants from major national and international agencies and to produce numerous publications in highly prominent journals. He has served on a number of national committees, including the Clinical Trials Review Panel at the Canadian Institutes of Health Research, the acting chair of the Safety and Efficacy Review Committee of the CTN, and a member of the Data Safety Monitoring Board at the National Cancer Institute of Canada.